Authors

• Xiaobei Guo
• Minjiang Chen (ORCID: https://orcid.org/0000-0002-4040-6115)
• Wei Song (ORCID: https://orcid.org/0000-0003-0988-1097)
• Paul Van Schil (ORCID: https://orcid.org/0000-0002-1962-8821)
• Qi He
• Tong Zhang (ORCID: https://orcid.org/0000-0002-4041-0499)
• Yuequan Shi
• Jing Zhao (ORCID: https://orcid.org/0000-0002-1198-0556)
• Jian Fang (ORCID: https://orcid.org/0000-0002-1077-3686)
• Haoran Zhang (ORCID: https://orcid.org/0000-0002-6020-8167)
• Hui Zhang (ORCID: https://orcid.org/0000-0001-6171-4785)
• Xiaoling Chen (ORCID: https://orcid.org/0009-0007-0325-4339)
• Wei Zhong (ORCID: https://orcid.org/0000-0002-5720-4528)
• Mengzhao Wang (ORCID: https://orcid.org/0000-0002-9226-5393)
• Yan Xu (ORCID: https://orcid.org/0000-0002-9596-2979)
• Zhimin Zeng (ORCID: https://orcid.org/0000-0002-0417-9752)
• Cuimin Ding
• J. A. Pang (ORCID: https://orcid.org/0009-0005-4304-4681)
• Zhen Huo
• Anwen Liu (ORCID: https://orcid.org/0009-0004-9534-2317)
• Jinghui Wang (ORCID: https://orcid.org/0000-0002-4999-2106)

Institutions

• Nanchang University (CN)
• Capital Medical University (CN)
• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Peking University (CN)
• Peking Union Medical College Hospital (CN)
• Peking University Cancer Hospital (CN)
• Antwerp University Hospital (BE)
• Beijing Chest Hospital (CN)
• Second Affiliated Hospital of Nanchang University (CN)

Publication Details

Journal

Translational Lung Cancer Research

Published

2025-05-01

DOI

https://doi.org/10.21037/tlcr-2025-271

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00